Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20160813029327N19
IRCT20160813029327N19
Completed
Phase 3

Evaluation of the efficacy of the methylphenidate in combination with magnesium and methylphenidate with placebo in patients with attention deficit hyperactivity disorder

Islamic Azad University0 sites62 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Islamic Azad University
Enrollment
62
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age between 8\-16 years old
  • •Diagnosis of ADHD by the pediatric psychiatrist
  • •Lack of mental retardation
  • •No history of epilepsy and seizure
  • •Intake methylphenidate tablet as the main method of drug therapy
  • •Consent of the patient and parents to participate in the research

Exclusion Criteria

  • •Renal failure
  • •intolerance to magnesium

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan City
IRCT2015092624209N1Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Completed
Phase 3
Investigating the effectiveness of methylphenidate and multi chain polyunsaturated fatty acids in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan CityAttention deficit hyperactivity disorder (ADHD).Disturbance of activity and attention
IRCT2015092724209N2Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40
Completed
Phase 3
Methylphenidate and atomoxetine in attention deficit hyperactivity disorder
IRCT20110802007202N15Tehran University of Medical Sciences36
Recruiting
Phase 1
Evaluation of the efficacy of Methylphenidate and modafinil in the treatment of excessive daily sleepiness in patients with drug-resistant epilepsy and comparison with the control groupEpilepsy.Epilepsy and recurrent seizures
IRCT20171030037093N22Esfahan University of Medical Sciences84
Completed
Not Applicable
Effects of massage on students with ADHDAttention Deficit/ Hyperactivity Disorders.Disturbance of activity and attention
IRCT201305142531N2Qom University of Medical Sciences30